IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and te...
AI Power Squeeze Reshapes Mid-2026 Capital Flows: From Software Premiums to Grid Infrastructure
ICCM: First FDA-cleared minimally invasive cryoablation device for breast cancer, driving global growth
IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation
IceCure Medical publishes investor presentation on ProSense FDA-cleared cryoablation treatment for low-risk breast cancer
12 Health Care Stocks Moving In Wednesday's After-Market Session
IceCure Medical Notifies Availability of Brazil ProSense Adoption Update Press Release